ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 112,13
-0,12%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Madrigal Pharmaceuticals Inc (MDGL)

  7. Madrigal Pharmaceuticals Inc (MDGL) Actualités

MDGL Madrigal Pharmaceuticals Inc

277,59
0,57 (0,21%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Madrigal Pharmaceuticals Inc MDGL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,57 0,21% 277,59 06:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
275,00 268,07 280,00 277,59 277,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/6/202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:17EDGAR2Form 144 - Report of proposed sale of securities
14/6/202422:37EDGAR2Form 144 - Report of proposed sale of securities
13/6/202423:53EDGAR2Form 144 - Report of proposed sale of securities
12/6/202423:03EDGAR2Form 144 - Report of proposed sale of securities
11/6/202423:39EDGAR2Form 144 - Report of proposed sale of securities
07/6/202400:48EDGAR2Form 144 - Report of proposed sale of securities
06/6/202414:00GLOBEMadrigal Pharmaceuticals Announces New Data from the Phase 3..
05/6/202414:00GLOBEMadrigal Pharmaceuticals to Participate in the Goldman Sachs..
29/5/202414:00GLOBEMadrigal Pharmaceuticals to Present Multiple Rezdiffra™..
24/5/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:36EDGAR2Form 8-K - Current report
07/5/202422:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/5/202422:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/5/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:06EDGAR2Form 8-K - Current report
07/5/202413:00GLOBEMadrigal Pharmaceuticals Reports First-Quarter 2024..
24/4/202422:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
23/4/202414:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
16/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
09/4/202414:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
03/4/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
19/3/202404:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
18/3/202421:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
15/3/202412:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
14/3/202421:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
06/3/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
05/3/202414:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
28/2/202413:10EDGAR2Form 8-K - Current report
28/2/202413:01EDGAR2Form 8-K - Current report
28/2/202413:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
28/2/202413:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
28/2/202412:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
14/2/202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
06/2/202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
29/1/202414:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
26/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
MDGL
Madrigal Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés